Lipid Microbubble Stability via Phase Transition Tuning
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current ultrasound contrast agents have microbubbles that are large and unstable, making it difficult to achieve sufficient accumulation in target tissues within a limited time, as they are prone to degradation in blood circulation.
Innovation Solution
A suspension of gas-filled microbubbles in a physiologically acceptable liquid carrier, comprising a lipid mixture with specific ratios of lipids such as DPPC or DPPG and PEGylated DSPE, providing enhanced thermal and in vivo stability and longevity as ultrasound contrast agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Illumination intensity
If microbubbles are made larger to improve echo enhancement, then imaging quality improves, but circulation time and stability deteriorate
Solution Approach 1:
The patent changes the physical-chemical parameters of the microbubble shell by using specific lipid compositions (DPPC, DSPC, cholesterol) with defined transition temperatures and ratios. This optimization of shell parameters enables microbubbles to maintain stability and flexibility at smaller sizes (1-5 μm) while still providing sufficient echo enhancement and prolonged circulation time in the bloodstream.
Solution Approach 2:
The patent employs a composite lipid shell structure comprising multiple lipid components (DPPC, DSPC, cholesterol) with complementary properties. DPPC provides structural integrity with its 41°C transition temperature, DSPC adds stability with 55°C transition temperature, and cholesterol modulates membrane fluidity. This composite material approach creates a synergistic shell that enhances both imaging performance and circulation longevity.
2Duration of action of moving object
If microbubbles are made smaller to improve circulation, then stability improves, but echo enhancement capability deteriorates
Solution Approach 1:
The patent optimizes shell composition parameters including lipid ratios (DPPC:DSPC:cholesterol), transition temperatures (41°C and 55°C), and shell thickness to create microbubbles that maintain high echogenicity at small sizes (1-5 μm). The specific parameter组合 enables small microbubbles to resonate effectively at diagnostic ultrasound frequencies, providing strong echo signals despite their small size.
3Duration of action of stationary object
If lipid composition is optimized for thermal stability, then in vivo longevity improves, but manufacturing complexity increases
Solution Approach 1:
The patent defines specific parameter ranges for lipid composition (DPPC 40-63 wt%, DSPC 20-40 wt%, cholesterol 10-20 wt%) and transition temperatures (41°C and 55°C) that balance thermal stability with manufacturing feasibility. These parameter specifications enable reproducible production of stable microbubbles using conventional encapsulation techniques without requiring overly complex manufacturing processes.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The microbubbles exhibit high concentration and stability, leading to improved echo enhancement and prolonged effective imaging time, suitable for diagnostic applications like local liver lesion diagnosis.
Implementation Method 1
a first lipid having transition temperature of about 41° C., a second lipid having transition temperature of about 55° C.
Implementation Method 2
provide a significant echo-enhancement of perfusion in ultrasound imaging
Data Source
AI summary
Disclosed is a suspension of gas-filled microbubbles in a physiologically acceptable liquid carrier comprising a lipid mixture of a first lipid having transition temperature of about 41° C. such as DPPC or DPPG, a second lipid having transition temperature of about 55° C. such as DSPC or DSPG, and a PEGylated DSPE such as DSPE-PEG2000, DSPE-PEG3000, or DSPE-PEG5000, and methods of preparation thereof.